71th meeting of the COVID-19 advisory boardof Ministry of Health, Labour and Welfare (February 9, 2022). Material 1
Effective reproduction number: On a national basis, the most recent number is above 1 (1.07; as of January 24), while the figure stands at 1.09 in the Tokyo metropolitan area and 1.06 in the Kansai area.
* The value for new cases of infection is the number of persons per 100,000 among the total number for the latest week, based on reporting dates.
The number of new cases of infection has increased continuously to approximately 459 (approximately 669 in Sapporo City), with a ratio to that for the previous week of 1.30. The infected individuals are mainly in their 30s or younger. The use rate of beds is approximately 30%.
In Aomori, the number of new cases of infection has increased continuously to approximately 221, with a ratio to that for the previous week of 1.18. The infected individuals are mainly in their 30s or younger. The use rate of beds is slightly more than 30%. In Yamagata and Fukushima, the number of new cases of infection has also increased continuously, to approximately 171 and 194, respectively. Both prefectures show an increase, with a ratio to that for the previous week of more than 1. The use rate of beds is slightly more than 40% in Yamagata and Fukushima.
In Gunma, the number of new cases of infection is approximately 347, with a ratio to that for the previous week of less than 1 (0.99). The infected individuals are mainly in their 30s or younger. The use rate of beds is slightly less than 60%. In Ibaraki and Tochigi, the number of new cases of infection has increased continuously, to approximately 346 and 300, respectively. Both prefectures show an increase, with a ratio to that for the previous week of more than 1. The use rate of beds is slightly more than 30% in Ibaraki and Tochigi.
Tokyo continues to show an increase in the number of new cases of infection. The number has reached the highest value in Japan (approximately 926), with a ratio to that for the previous week of 1.21. The infected individuals are mainly in their 30s or younger, while the number of those aged less than 10 years is also increasing. The use rate of beds is slightly more than 50%, while the use rate of beds for severe patients is approximately 40%. In Saitama, Chiba, and Kanagawa, the number of new cases of infection has also increased continuously, to approximately 550, 537, and 613, respectively. All of these prefectures show an increase, with a ratio to that for the previous week of more than 1. The use rate of beds is slightly less than 70% in Saitama, slightly more than 60% in Chiba, and slightly less than 70% in Kanagawa. The use rate of beds for severe patients is approximately 40% in Kanagawa.
In Ishikawa, the number of new cases of infection has increased continuously to approximately 297, with a ratio to that for the previous week of 1.20. The infected individuals are mainly in their 30s or younger. The use rate of beds is slightly more than 50%. In Niigata and Nagano, the number of new cases of infection has also increased continuously, to approximately 156 and 193, respectively. The use rate of beds is slightly more than 30% in Niigata and slightly more than 90% in Nagano.
In Aichi, the number of new cases of infection has increased continuously to approximately 521, with a ratio to that for the previous week of 1.13. The infected individuals are mainly in their 30s or younger. The use rate of beds is slightly more than 50%. In Gifu, Shizuoka, and Mie, the number of new cases of infection has also increased continuously, to approximately 302, 324, and 292, respectively. All of these prefectures show an increase, with a ratio to that for the previous week of more than 1. The use rate of beds is slightly more than 50% in Gifu and Shizuoka, and slightly less than 50% in Mie.
In Osaka, the number of new cases of infection has increased continuously to approximately 871, with a ratio to that for the previous week of 1.15. The infected individuals are mainly in their 30s or younger. The use rate of beds is approximately 90%, while the use rate of beds for severe patients is slightly more than 40%. In Kyoto, Hyogo, and Wakayama, the number of new cases of infection has also increased continuously, to approximately 689, 714, and 387, respectively. All of these prefectures show an increase, with a ratio to that for the previous week of more than 1. The use rate of beds is slightly less than 60% in Kyoto and slightly more than 70% in Hyogo. The use rate of beds for severe patients is slightly more than 50% in Kyoto and slightly more than 20% in Hyogo.
In Hiroshima, the number of new cases of infection is approximately 267, with a ratio to that for the previous week of less than 1 (0.81). The infected individuals are mainly in their 30s or younger. The use rate of beds is slightly more than 50%, while the use rate of beds for severe patients is slightly more than 30%. In Shimane and Yamaguchi, the number of new cases of infection has also decreased to approximately 77 and 161, respectively, with a ratio to that for the previous week of less than 1 (0.89 and 0.85, respectively). In Okayama and Kagawa, the number of new cases of infection has increased continuously, to approximately 391 and 246, respectively. Both prefectures show a continuous increase, with a ratio to that for the previous week of more than 1. The use rate of beds is approximately 30% in Shimane, slightly more than 50% in Okayama, slightly more than 40% in Yamaguchi, and slightly more than 50% in Kagawa.
In Fukuoka, the number of new cases of infection has increased continuously to approximately 642, with a ratio to that for the previous week of 1.17. The infected individuals are mainly in their 30s or younger. The use rate of beds is slightly more than 80%. In Saga, Oita, and Kagoshima, the number of new cases of infection has increased continuously, to approximately 432, 269, and 263, respectively. All of these prefectures show an increase, with a ratio to that for the previous week of more than 1. In Nagasaki, Kumamoto, and Miyazaki, the number of new cases of infection is 276, 344, and 213, respectively, with a ratio to that for the previous week of less than 1 (0.91, 0.85. and 0.86, respectively). The use rate of beds is slightly more than 30% in Saga, slightly more than 40% in Nagasaki and Miyazaki, slightly more than 60% in Kumamoto, slightly more than 40% in Oita, and slightly less than 60% in Kagoshima. The use rate of beds for severe patients is slightly more than 20% in Kumamoto.
The number of new cases of infection is approximately 295, and the ratio to that for the previous week remains less than 1 (0.67). In the Yaeyama district, the increase is continuing. The newly infected individuals are mainly in their 30s or younger. The use rate of beds is approximately 60%, while the use rate of beds for severe patients is slightly more than 50%.
In Iwate, Miyagi, Toyama, Fukui, Shiga, Nara, Tokushima, and Kochi, the number of new cases of infection is approximately 84, 198, 203, 200, 496, 516, 169, and 225, respectively. All of these prefectures show an increase, with a ratio to that for the previous week of more than 1. In Akita, Yamanashi, Tottori, and Ehime, the number of new cases of infection is 132, 235, 122, and 133, respectively, with a ratio to that for the previous week of less than 1 (0.82, 0.82, 0.65, and 0.87, respectively). The use rate of beds is slightly more than 40% in Iwate, slightly more than 30% in Miyagi, Akita, Toyama, and Tokushima, approximately 20% in Fukui, slightly more than 50% in Yamanashi, approximately 60% in Shiga, slightly more than 70% in Nara, slightly more than 20% in Tottori, slightly less than 40% in Ehime, and approximately 40% in Kochi.
It has been confirmed that compared to the Delta variant, the generation time has shortened to approximately 2 days (approximately 5 days for Delta). The doubling time and incubation period have also shortened, the risk of re-infection and secondary infection after infection has increased, and the speed of infection spread is very fast. As the obtained data indicates that the serial interval is shorter than the incubation period in individuals infected with the Omicron variant, its transmission before disease onset probably occurs to a certain extent, as in the case of infection with the conventional strain.
In Japan, many cases of infection occur through the same opportunities as before (spending time indoors with insufficient ventilation, eating and drinking, etc.), and infection is considered to occur via the same routes as before (droplets, aerosol inhalation, contact infection, etc.).
It has been suggested that infection with the Omicron variant may present a relatively lower risk of hospitalization and aggravation than does the Delta variant. However, the number of cases of hospitalization due to the Omicron variant infection has already increased.
Viral shedding in individuals infected with the Omicron variant decreases over time, regardless of vaccination status. In patients with symptoms, it has been shown that the possibility of viral shedding after Day 10 (when the date of onset is regarded as Day 0) is as low as in the case of infection with the conventional strain. In patients with no symptoms, it has been shown that the possibility of viral shedding is low 8 days after the date of diagnosis.
For infection with the Omicron variant, the preventive effect of a first vaccination against disease onset is markedly reduced, but its preventive effect on hospitalization is maintained at a certain level. It has also been reported that a booster shot improves the preventive effects against disease onset and hospitalization for infection with the Omicron variant.
In some areas overseas, the number of cases of infection with the BA.2 lineage is increasing. Currently, the mainstream of the Omicron variant in Japan is the BA.1 lineage, but the BA.2 lineage has also been detected in quarantine and in Japan. Monitoring must be continued through a certain number of genome analyses. Analyses of the effective reproduction number, risk of domestic secondary infection, and other indices have shown that the infectivity of the BA.2 lineage is higher than that of the BA.1 lineage. According to a report from Denmark, there is no difference in the risk of hospitalization between the BA.1 lineage and the BA.2 lineage, in terms of severity. In addition, a report from the UK says that there is no difference in the preventive effect of vaccination between these lineages.
A test/diagnosis system and the processing of notifications to public health centers are becoming strained, and there are concerns regarding discrepancies between the published data and the actual status. It is necessary to consider effective and appropriate surveillance, in order to properly grasp the trend of occurrences. Tests and active epidemiological surveys should be prioritized based on the findings obtained thus far. Regarding free tests for people who are worried about infection and wish to undergo testing, attention should be paid to a rapid increase in demand for tests as well as test availability, and a system to ensure prioritized testing needs to be secured.
While the infection is spreading nationwide, it is necessary to maintain a surveillance system according to the local infection status, including the situation regarding replacement with the Omicron variant. For severe patients, clusters, or other applicable cases, a genome analysis should also be performed to identify variants such as the Delta variant.
Based on the infection status of the region and forecasts of the numbers of infected cases and severe cases, local governments must work flexibly to secure the required number of beds and healthcare professionals, secure the functions of public health centers, which are indispensable for local communities, along with support for strengthening the healthcare center system, and establish home-visit and online medical care systems for home care recipients. At that time, it is necessary to secure a system for prompt administration of oral therapeutic drugs and neutralizing antibody drugs, for patients at risk of developing severe disease, such as elderly patients and patients with underlying diseases. As patients with acute diseases other than COVID-19 who require emergency transportation often appear during the winter, attention should be given to the balance between medical care for COVID-19 and regular medical care. If the infection spreads rapidly, it will be necessary to secure prompt access to consultation and condition monitoring for those at a higher risk of developing severe disease. Furthermore, it is also necessary to establish a system that enables COVID-19 patients with an underlying disease to continue treatment for the underlying disease.
Local governments are required to promote the provision of information on vaccination. Booster vaccinations, which have already been started, must also be implemented steadily, along with vaccinations for unvaccinated persons. The number of infected individuals among the elderly may continue to increase in the future. Therefore, it is necessary to further accelerate vaccinations for the elderly and other eligible persons, and also to successively provide vaccination services ahead of the original schedule for the general public as well, as much as possible.
The waiting period after entering Japan has been further reduced from 10 days to 7 days. It is necessary to continue to verify future quarantine measures, while taking into account the prevalence of variants such as the Omicron variant in Japan and overseas. For individuals found to be positive by an entrance test, a whole-genome analysis should continue to be performed, to monitor the strains that are spreading overseas.
Based on the situation where the infection is spreading due to the Omicron variant, a proposal has just been made at the meeting of the Subcommittee on Novel Coronavirus Disease Control held on February 4. In situations/places where the infection is spreading, prevention measures based on the characteristics of the Omicron variant should be strengthened and thoroughly implemented.
Figures (Number of new infections reported etc.) (PDF)
70th meeting of the COVID-19 advisory board of Ministry of Health, Labour and Welfare (February 2, 2022). Material 1
Effective reproduction number: On a national basis, the most recent number is above 1 (1.19; as of January 17), and the figure stands at 1.23 in the Tokyo metropolitan area and 1.19 in the Kansai area.
* The value for new cases of infection is the number of persons per 100,000 among the total number for the latest week, based on reporting dates.
The number of new cases of infection has increased continuously to approximately 353 (approximately 505 in Sapporo City), with a ratio to that for the previous week of 1.7. The infected individuals are mainly in their 30s or younger. The use rate of beds is slightly less than 30%.
In Aomori, the number of new cases of infection has increased continuously to approximately 186, with a ratio to that for the previous week of 1.7. The infected individuals are mainly in their 20s or younger. The use rate of beds is slightly more than 20%. In Yamagata and Fukushima, the number of new cases of infection has also increased continuously, to approximately 132 and 152, respectively. Both prefectures show a rapid increase, with a ratio to that for the previous week of more than 2. The use rate of beds is slightly more than 20% in Yamagata and slightly more than 40% in Fukushima.
In Gunma, the number of new cases of infection has increased continuously to approximately 349, with a ratio to that for the previous week of 1.5. The infected individuals are mainly in their 30s or younger. The use rate of beds is slightly more than 50%. In Ibaraki and Tochigi, the number of new cases of infection has also increased continuously, to approximately 222 and 230, respectively. Both prefectures show an increase, with a ratio to that for the previous week of more than 1. The use rate of beds is slightly more than 30% in both prefectures.
Tokyo continues to show a rapid increase in the number of new cases of infection. The number has reached the highest value in Japan (approximately 767), with a ratio to that for the previous week of 1.6. The infected individuals are mainly in their 20s and 30s, while the number of those aged less than 10 years are also increasing. The use rate of beds is slightly less than 50%, while the use rate of beds for severe patients is slightly more than 30%. In Saitama, Chiba, and Kanagawa, the number of new cases of infection has also increased continuously, to approximately 399, 392, and 504, respectively. Both prefectures show an increase, with a ratio to that for the previous week of more than 1. The use rate of beds is slightly less than 60% in Saitama, and slightly less than 50% in Chiba and Kanagawa.
In Ishikawa, the number of new cases of infection has increased continuously to approximately 248, with a ratio to that for the previous week of 1.7. The infected individuals are mainly in their 20s or younger. The use rate of beds is slightly more than 40%. In Niigata and Nagano, the number of new cases of infection has also increased continuously, to approximately 152 and 189, respectively. Both prefectures show an increase, with a ratio to that for the previous week of more than 1. The use rate of beds is slightly more than 20% in Niigata and slightly more than 60% in Nagano.
In Aichi, the number of new cases of infection has increased continuously to approximately 462, with a ratio to that for the previous week of 1.6. The infected individuals are mainly in their 30s or younger. The use rate of beds is slightly more than 50%. In Gifu, Shizuoka, and Mie, the number of new cases of infection has also increased continuously, to approximately 273, 276, and 231, respectively. Both prefectures show an increase, with a ratio to that for the previous week of more than 1. The use rate of beds is slightly more than 60% in Gifu, slightly more than 30% in Shizuoka, and slightly more than 40% in Mie.
In Osaka, the number of new cases of infection has increased continuously to approximately 760, with a ratio to that for the previous week of 1.5. The infected individuals are mainly in their 30s or younger. The use rate of beds is slightly more than 70%, while the use rate of beds for severe patients is slightly more than 30%. In Kyoto and Hyogo, the number of new cases of infection has also increased continuously, to approximately 600 and 549, respectively. Both prefectures show an increase, with a ratio to that for the previous week of more than 1. The use rate of beds is slightly more than 50% in Kyoto and slightly more than 60% in Hyogo. The use rate of beds for severe patients is approximately 40% in Kyoto.
In Hiroshima, the number of new cases of infection is approximately 328, with a ratio to that for the previous week of less than 1 (0.98). The infected individuals are mainly in their 30s or younger. The use rate of beds is approximately 50%, while the use rate of beds for severe patients is slightly more than 20%. In Okayama, Yamaguchi, and Kagawa, the number of new cases of infection has also increased continuously, to approximately 320, 190, and 241, respectively. In Shimane, the number of new cases of infection has decreased to approximately 87, with a ratio to that for the previous week of less than 1 (0.5). In Okayama, Yamaguchi, and Kagawa, the number of new cases is continuing to increase, with a ratio to that for the previous week of more than 1. The use rate of beds is slightly more than 30% in Shimane, slightly more than 40% in Okayama, approximately 50% in Yamaguchi, and slightly more than 30% in Kagawa.
In Fukuoka, the number of new cases of infection has increased continuously to approximately 548, with a ratio to that for the previous week of 1.6. The infected individuals are mainly in their 30s or younger. The use rate of beds is slightly less than 50%. In Saga, Nagasaki, Kumamoto, Oita, Miyazaki, and Kagoshima, the number of new cases of infection has increased continuously, to approximately 362, 302, 406, 247, 247, and 248, respectively. Both prefectures show an increase, with a ratio to that for the previous week of more than 1. The use rate of beds is approximately 40% in Saga, slightly less than 40% in Nagasaki and Miyazaki, slightly more than 70% in Kumamoto, slightly more than 40% in Oita, and slightly more than 50% in Kagoshima.
The number of new cases of infection is approximately 439, and the ratio to that for the previous week remains less than 1 (0.8). In the Yaeyama district, the increase is continuing. The newly infected individuals are mainly in their 30s or younger, while the number of those in their 70s is increasing. The use rate of beds is slightly less than 70%, while the use rate of beds for severe patients is approximately 60%.
In Iwate, Miyagi, Akita, Toyama, Fukui, Yamanashi, Shiga, Nara, Wakayama, Tottori, Tokushima, Ehime, and Kochi, the number of new cases of infection is approximately 72, 151, 161, 149, 171, 289, 375, 460, 341, 189, 137, 153, and 174, respectively. In some areas, the number has increased rapidly, with a ratio to that for the previous week of more than 2. The use rate of beds is slightly more than 60% in Iwate, Shiga, and Wakayama, slightly more than 70% in Yamanashi and Nara, slightly more than 30% in Toyama, Tokushima, Ehime, and Kochi, and slightly more than 20% in Miyagi, Akita, and Tottori.
It has been confirmed that compared to the Delta variant, the generation time has shortened to approximately 2 days (approximately 5 days for Delta). The doubling time and incubation period have also shortened, the risk of re-infection and secondary infection after infection has increased, and the speed of infection spread is very fast.
In Japan, many cases of infection occur through the same opportunities as before (spending time indoors with insufficient ventilation, eating and drinking, etc.), and infection is considered to occur via the same routes as before (droplets, aerosol inhalation, contact infection, etc.).
It has been suggested that infection with the Omicron variant may present a relatively lower risk of hospitalization and aggravation than does the Delta variant. However, the number of cases of hospitalization due to the Omicron variant infection has already increased.
Viral shedding in individuals infected with the Omicron variant decreases over time, regardless of vaccination status. In patients with symptoms, it has been shown that the possibility of viral shedding after Day 10 (when the date of onset is regarded as Day 0) is as low as in the case of infection with the conventional strain. In patients with no symptoms, it has been shown that the possibility of viral shedding is low 8 days after the date of diagnosis.
For infection with the Omicron variant, the preventive effect of a first vaccination against disease onset is markedly reduced, but its preventive effect on aggravation is maintained at a certain level. It has also been reported that booster shot improves the infection-preventing effect and hospitalization-preventing effect for infection by the Omicron variant.
A test/diagnosis system and the processing of notifications to public health centers are becoming strained, and there are concerns regarding discrepancies between the published data and the actual status. It is necessary to consider effective and appropriate surveillance, in order to properly grasp the trend of occurrences. Tests and active epidemiological surveys should be prioritized based on the findings obtained thus far. Regarding free tests for people who are worried about infection and wish to undergo testing, attention should be paid to a rapid increase in demand for tests as well as test availability, and a system to ensure prioritized testing needs to be secured.
While the infection is spreading nationwide, it is necessary to maintain a surveillance system according to the local infection status, including the situation regarding replacement with the Omicron variant. For severe patients, clusters, or other applicable cases, a genome analysis should also be performed to identify variants such as the Delta variant. In addition, in some areas overseas, the number of cases of infection with the BA.2 lineage is increasing. Currently, the mainstream of the Omicron variant in Japan is the BA.1 lineage, but the BA.2 lineage has also been detected in quarantine and in Japan. Monitoring must be continued by a certain number of genome analyses. In comparison between the BA.1 and BA.2 lineages, differences in hospitalization rates are not clear at this time.
Based on the infection status of the region and forecasts of the numbers of infected cases and severe cases, local governments must work flexibly to secure the required number of beds and healthcare professionals, secure the functions of public health centers, which are indispensable for local communities, along with support for strengthening the healthcare center system, and establish home-visit and online medical care systems for home care recipients. At that time, it is necessary to secure a system for prompt administration of oral therapeutic drugs and neutralizing antibody drugs, for patients at risk of developing severe disease, such as elderly patients and patients with underlying diseases. As patients with acute diseases other than COVID-19 who require emergency transportation often appear during the winter, attention should be given to the balance between medical care for COVID-19 and regular medical care. If the infection spreads rapidly, it is necessary to take concrete actions to ensure that people have prompt access to consultation and condition monitoring according to the infection status in the area, and to prevent a collapse of outpatient care services.
It is particularly important to promote the vaccination of unvaccinated persons. Local governments are required to provide information to persons who have not been vaccinated. At the same time, booster vaccinations, which have already been started, must also be implemented steadily. The number of elderly infected individuals may continue to increase in the future. Therefore, it is necessary to further accelerate vaccinations for the elderly and other eligible persons, and also to successively provide vaccination services ahead of the original schedule for the general public as well, as much as possible.
The waiting period after entering Japan has been further reduced from 10 days to 7 days. It is necessary to continue to verify future quarantine measures, while taking into account the prevalence of variants such as the Omicron variant in Japan and overseas. For individuals found to be positive by an entrance test, a whole-genome analysis should continue to be performed, to monitor the strains that are spreading overseas.
Figures (Number of new infections reported etc.) (PDF)
69th meeting of the COVID-19 advisory board of Ministry of Health, Labour and Welfare (January 26, 2022). Material 1
Effective reproduction number: On a national basis, the most recent number is above 1 at 1.37 (as of January 9). The figure is 1.45 in the Tokyo metropolitan area and 1.42 in the Kansai area.
* The value for new cases of infection is the number of people per 100,000 among the total number for the latest week, based on reporting dates.
In Tokyo, the number of new cases of infection has increased rapidly to approximately 482, with a ratio of this week to last week of 2.5. Most are in their 20s and 30s, but those in their teens or younger are also increasing. The use rate of beds is slightly more than 30%, and the use rate of beds for severe cases is about 30%. Also in Saitama, Chiba and Kanagawa, the number of new cases of infection continued to increase, reaching approximately 254, 256, and 278, respectively. In each of these prefectures, the ratio of new cases for this week to last week increased rapidly, to above 2. The use rate of beds is about 40% in Saitama, about 30% in Chiba and slightly more than 30% in Kanagawa.
In Gunma, the number of new cases of infection has increased rapidly to approximately 230, with a ratio of this week to last week of 2.4. The infected individuals are mainly in their 20s or younger. The use rate of beds is slightly more than 50%. In Niigata, the number of new cases of infection has increased rapidly to approximately 141, with a ratio of this week to last week of 1.9. The infected individuals are mainly in their 20s or younger. The use rate of beds is slightly more than 20%.
In Aichi, the number of new cases of infection continued to increase rapidly to approximately 295, with a ratio of this week to last week of 2.5. The infected individuals are mainly in their 20s or younger. The use rate of beds is slightly more than 20%. In Gifu and Mie, the number of new cases of infection has increased to approximately 188 and 142, respectively. In Gifu, the ratio of new cases for this week to last week increased rapidly, to above 2. The use rate of beds is slightly more than 50% in Gifu and slightly more than 30% in Mie.
In Hiroshima, the number of new cases of infection continued to increase to approximately 334, with a ratio of this week to last week of 1.4. The infected individuals are mainly in their 30s or younger. The use rate of beds is approximately 40%. In Yamaguchi and Kagawa, the number of new cases of infection continued to increase to approximately 171 and 124, respectively. In Kagawa, the ratio of new cases for this week to last week increased rapidly, to above 2. The use rate of beds is about 50% in Yamaguchi, about 40% in Kagawa.
In Kumamoto, the number of new cases of infection continued to increase to approximately 284, with a ratio of this week to last week of 1.8. The infected individuals are mainly in their 20s or younger. The use rate of beds is slightly less than 50%. In Nagasaki and Miyazaki, the number of new cases of infection continued to increase to approximately 249 and 192, respectively. In each of these prefectures, the ratio of new cases for this week to last week increased rapidly, to above 2. The use rate of beds is slightly more than 30% in both.
The number of new cases of infection for this week to last week is 0.8, which is below 1, but it must be noted that the number reported may not reflect the actual situation. At about 547 it was the highest in Japan. Newly infected patients are mainly in their 30s or younger, but those younger than 10 and those in their 60s and older are increasing. The use rate of beds is slightly more than 60%, and the use rate of beds for severe cases is slightly less than 70%.
The number of new cases of infection is increasing rapidly and has reached approximately 202 (approximately 284 in Sapporo City), with a ratio of this week to last week of 2.8. The infected individuals are mainly in their 20s or younger. The use rate of beds is slightly more than 20%.
In Osaka, the number of new cases of infection continued to increase rapidly to approximately 513, with a ratio of this week to last week of 2.0. The infected individuals are mainly in their 20s or younger. The use rate of beds is about 50%, and the use rate of beds for severe cases is about 20%. In Shiga, Kyoto, Hyogo, Nara, and Wakayama, the number of new cases of infection continued to increase, reaching approximately 246, 374, 340, 248, and 213, respectively. In Kyoto, Hyogo, and Nara, the ratio of new cases for this week to last week increased rapidly, to above 2. The use rate of beds is slightly more than 40% in Shiga, slightly more than 30% in Kyoto, approximately 60% in Nara, slightly more than 40% in Hyogo, and slightly more than 70% in Wakayama. The use rate of beds for severe cases is slightly more than 20% in Kyoto and Wakayama, and slightly less than 30% in Nara.
In Fukuoka, the number of new cases of infection continued to increase rapidly to approximately 350, with a ratio of this week to last week of 2.7. The infected individuals are mainly in their 20s or younger. The use rate of beds is slightly more than 20%. In Saga, Oita, and Kagoshima, the number of new cases of infection continued to increase, reaching approximately 224, 192, and 153, respectively. In Oita and Kagoshima, the ratio of new cases for this week to last week increased rapidly, to above 2. The use rate of beds is slightly more than 30% in Saga, about 40% in Oita and slightly less than 40% in Kagoshima.
Aomori, Iwate, Miyagi, Akita, Yamagata, Fukushima, Ibaraki, Tochigi, Toyama, Ishikawa, Fukui, Yamanashi, Nagano, Shizuoka, Tottori, Shimane, Okayama, Tokushima, Ehime, and Kochi were approximately 112, 29, 71, 73, 58, 51, 142, 161, 59, 143, 100, 164, 153, 206, 114, 161, 199, 64, 135, and 90, respectively. The use rate of beds is about 20% in Aomori, and about 30% in Iwate. It is slightly less than 30% in Yamagata and Okayama, slightly less than 40% in Fukushima, Nagano and Kochi, slightly more than 20% in Ibaraki, Toyama, Shizuoka, Tottori, Tokushima and Ehime, slightly more than 30% in Tochigi, Ishikawa and Shimane, and slightly more than 50% in Yamanashi.
It has been confirmed that compared to the Delta variant, the generation time has shortened to approximately 2 days (approximately 5 days for Delta). The doubling time and incubation period have also shortened, the risk of re-infection and secondary infection after infection has increased, and the speed of infection spread is very fast.
In Japan, many infections occur from the same opportunities as before (indoors with insufficient ventilation, opportunities of eating and drinking, etc.), and the routes of infection are considered to be via droplets, aerosol inhalation, contact infection, etc. as before.
It has been suggested that infection with the Omicron variant may have a relatively lower risk of hospitalization and aggravation than the Delta variant, but in some areas, hospitalizations due to the Omicron variant infection have already increased.
Viral shedding in patients infected with the Omicron variant decreased over time regardless of vaccination status, showing that the possibility of viral shedding is low from 10days after onset or diagnosis, as with the conventional strain.
The preventive effect against infection with the Omicron variant by primary immunization is markedly reduced, but the preventive effect on aggravation is maintained at a certain level. It has also been reported that booster shot improves the infection-preventing effect and hospitalization-preventing effect for infection by the Omicron variant.
The test/diagnosis system and process of notification to public health centers are becoming strained, and there is concern that the published data may differ from the actual situation. Effective and appropriate surveillance must be considered in order to understand the trends of occurrence. Tests and active epidemiological surveys should be prioritized based on the findings so far. It is necessary to actively perform tests for employees at facilities for the elderly, based on the Basic Policies for Novel Coronavirus Disease Control. In addition, it has become possible to receive free tests for those who are worried about infection and wish to receive such tests. However, attention needs to be paid to the rapid increase in the demand for these tests as well as the ability of the tests, and a system to ensure prioritized testing needs to be secured.
While the spread of infection is progressing nationwide, it is necessary to continue the surveillance system according to the local infection status, including the situation of replacement with the Omicron variant. In severe cases and cluster cases, confirmation by genome analysis, including the Delta variant, is also required. In some areas overseas, infection by the BA.2 lineage is increasing. Currently, the mainstream of the Omicron variant in Japan is the BA.1 lineage, but the BA.2 lineage has also been detected in quarantine and in Japan. Monitoring must be continued by a certain number of genome analyses. In comparison between the BA.1 and BA.2 lineages, differences in hospitalization rates are not clear at this time.
Based on the infection status of the region and forecasts of the numbers of infected cases and severe cases, local governments must work flexibly to secure the required number of beds and healthcare professionals, secure the functions of public health centers, which are indispensable for local communities, along with support for strengthening the healthcare center system, and establish home-visit and online medical care systems for home care recipients. At that time, it is necessary to secure a system for prompt administration of oral therapeutic drugs and neutralizing antibody drugs for patients at risk of developing severe disease, such as elderly patients and patients with underlying diseases. At the same time, attention should be paid to the balance with ordinary medical care. If the infection spreads rapidly, it is necessary to promptly take concrete action for consultations and health observation according to the infection situation in the area, and prevent dysfunction in outpatient care.
It is particularly important to promote the vaccination of unvaccinated people. Local governments are required to provide information to persons who have not been vaccinated. At the same time, booster vaccinations, which have already been started, must also be implemented steadily. In doing so, it is necessary to smoothly carry out an accelerated vaccination of healthcare professionals and the elderly.
It is necessary to regard those who are positive in the immigration inspection as positive for the Omicron variant, and to continue whole-genome analysis for positives, in order to monitor strains circulating overseas. The waiting period after entering Japan has been shortened to 10 days, but it is necessary to continue to verify future border control measures, including the waiting period, while taking into account the prevalence of the Omicron variant in Japan and overseas.
Figures (Number of new infections reported etc.) (PDF)
68th meeting of the COVID-19 advisory board of Ministry of Health, Labour and Welfare (January 20, 2022). Material 1
Effective reproduction number: On a national basis, the most recent number is above 1 at 1.43 (as of January 3). The figure is 1.45 in the Tokyo metropolitan area and 1.42 in the Kansai area.
* The value for new cases of infection is the number of people per 100,000 among the total number for the latest week, based on reporting dates.
The number of new cases of infection in Okinawa is 1.1 this week compared to last week, but it must be noted that the number reported may not reflect the actual situation. Furthermore, at about 673 it was the highest in Japan. Most are in their 20s or younger, but those in their teens or younger and those in their 60s or older are increasing. The use rate of beds is slightly less than 60%, and the use rate of beds for severe patients is slightly more than 60%. In Yamaguchi, the number of new cases of infection is approximately 130, and the ratio of this week to last week is 1.6. The use rate of beds is slightly more than 40%. In Hiroshima, the number of new cases of infection is approximately 257, and the ratio of this week to last week is 1.9. The use rate of beds is slightly more than 40%.
The number of new cases of infection is increasing rapidly, and has reached approximately 90 (approximately 120 in Sapporo City), with a ratio of this week to last week of 5.6. The infected individuals are mainly in their 20s or younger. The use rate of beds is slightly more than 10%.
The number of new cases of infection has continued to increase in Ibaraki, Tochigi, and Gunma, reaching approximately 66, 84, and 110, respectively. In each of these prefectures, the ratio of new cases for this week to last week increased rapidly, to above 2. The use rate of beds is slightly more than 20% in Tochigi and slightly less than 40% in Gunma.
In Tokyo, the number of new cases of infection has increased rapidly to approximately 229, with a ratio of this week to last week of 4.0. The infected individuals are mainly in their 20s or younger. The use rate of beds is slightly more than 20%, and the use rate of beds for severe patients is slightly less than 20%. Also in Saitama, Chiba and Kanagawa, the number of new cases of infection continued to increase, reaching approximately 129, 123, and 124, respectively. In each of these prefectures, the ratio of new cases for this week to last week increased rapidly, to above 2. The use rate of beds is approximately 30% in Saitama, slightly more than 10% in Chiba and slightly less than 20% in Kanagawa.
In Aichi, the number of new cases of infection continued to increase rapidly to approximately 148, with a ratio of this week to last week of 4.8. The infected individuals are mainly in their 20s or younger. The use rate of beds is slightly more than 10%. In Gifu, the number of new cases of infection continued to increase rapidly to approximately 97, with a ratio of this week to last week of 4.2. In Shizuoka and Mie, the number of new cases of infection has increased to approximately 103 and 85, respectively. In each of these prefectures, the ratio of new cases for this week to last week increased rapidly, to above 2. The use rate of beds is slightly less than 30% in Gifu and slightly more than 20% in Mie.
In Osaka, the number of new cases of infection continued to increase rapidly to approximately 303, with a ratio of this week to last week of 4.6. The infected individuals are mainly in their 20s or younger. The use rate of beds is slightly less than 30%. In Shiga, Kyoto, Hyogo, Nara, and Wakayama, the number of new cases of infection continued to increase, reaching approximately 149, 217, 169, 125, and 126, respectively. In each of these prefectures, the ratio of new cases for this week to last week increased rapidly, to above 2. The use rate of beds is approximately 50% in Shiga, approximately 30% in Kyoto, slightly less than 40% in Nara, slightly more than 30% in Hyogo, and slightly more than 80% in Wakayama.
In Fukuoka, the number of new cases of infection continued to increase rapidly to approximately 163, with a ratio of this week to last week of 5.9. The infected individuals are mainly in their 20s or younger. The use rate of beds is approximately 10%. In Saga, Nagasaki, Kumamoto, Oita, Miyazaki, and Kagoshima, the number of new cases of infection continued to increase, reaching approximately 140, 120, 185, 88, 89, and 75, respectively. In most areas, the ratio of new cases for this week to last week increased rapidly, to more than 2. The use rate of beds is slightly less than 30% in Saga, slightly more than 20% in Nagasaki, Oita, and Kagoshima, approximately 30% in Kumamoto, and slightly less than 20% in Miyazaki.
Aomori, Miyagi, Akita, Yamagata, Niigata, Ishikawa, Fukui, Yamanashi, Nagano, Tottori, Shimane, Okayama, Tokushima, Kagawa, Ehime, and Kochi were approximately 76, 30, 25, 26, 87, 57, 59, 94, 88, 63, 117, 95, 32, 61, 100, and 38, respectively. The use rate of beds is slightly more than 20% in Niigata, Kagawa, Ehime, and Kochi, slightly more than 30% in Yamagata and Yamanashi, slightly less than 30% in Nagano, slightly more than 30% in Tottori and Shimane, and approximately 20% in Tokushima.
It has been confirmed that compared to the Delta variant, the generation time has shortened to approximately 2 days (approximately 5 days for Delta). The doubling time and incubation period have also shortened, the risk of re-infection and secondary infection after infection has increased, and the speed of infection spread is very fast.
In Japan, many infections occur from the same opportunities as before (indoors with insufficient ventilation, opportunities of eating and drinking, etc.), and the routes of infection are considered to be via droplets, aerosol inhalation, contact infection, etc. as before.
It has been suggested that infection with the Omicron variant may have a relatively lower risk of hospitalization and aggravation than the Delta variant, but in some areas, hospitalizations due to the Omicron variant infection have already increased.
Viral shedding in patients infected with the Omicron variant decreased over time regardless of vaccination status, showing that the possibility of viral shedding is low from 10days after onset or diagnosis, as with the conventional strain.
The preventive effect against infection with the Omicron variant by primary immunization is markedly reduced, but the preventive effect on aggravation is maintained at a certain level. It has also been reported that booster shot improves the infection-preventing effect and hospitalization-preventing effect for infection by the Omicron variant.
While the spread of infection with the Omicron variant is progressing nationwide, it is necessary to continue the surveillance system according to the local infection status, including the situation of replacement with the Omicron variant. In regions experiencing a rapid spread of infection, it is necessary to prioritize tests and active epidemiological surveys based on the findings obtained thus far, and to change the treatment systems. It is also necessary to confirm the Delta variant in severe cases and cluster cases. Monitoring must be continued by a certain number of genome analyses.
Based on the infection status of the region and forecasts of the numbers of infected cases and severe cases, local governments must work flexibly to secure the required number of beds and healthcare professionals, secure the functions of public health centers, which are indispensable for local communities, along with support for strengthening the healthcare center system, and establish home-visit and online medical care systems for home care recipients. At that time, it is necessary to secure a system for prompt administration of oral therapeutic drugs and neutralizing antibody drugs for patients at risk of developing severe disease, such as elderly patients and patients with underlying diseases.
In regions where the infection is spreading, it is necessary to actively perform tests for employees at facilities for the elderly, based on the Basic Policies for Novel Coronavirus Disease Control. In addition, it has become possible to receive free tests for those who are worried about infection and wish to receive such tests. However, in regions where the infection is spreading rapidly, attention needs to be paid to the rapid increase in the demand for these tests as well as the ability of the tests, and a system to ensure prioritized testing needs to be secured.
It is particularly important to promote the vaccination of unvaccinated people, and local governments must enhance the communication of information to those who have not yet been vaccinated. At the same time, booster vaccinations, which have already been started, must also be implemented steadily. In doing so, it is necessary to smoothly carry out an accelerated vaccination of healthcare professionals and the elderly.
It is necessary to regard those who are positive in the immigration inspection as positive for the Omicron variant, and to continue whole-genome analysis for positives, in order to monitor strains circulating overseas. The waiting period after entering Japan has been shortened to 10 days, but it is necessary to continue to verify future border control measures, including the waiting period, while taking into account the prevalence of the Omicron variant in Japan and overseas.
Figures (Number of new infections reported etc.) (PDF)
67th meeting of the COVID-19 advisory board of Ministry of Health, Labour and Welfare (January 13, 2022). Material 1
Effective reproduction number: On a national basis, the most recent number is above 2, at 2.29 (as of December 28). The figure is 2.27 in the Tokyo metropolitan area and 1.98 in the Kansai area.
* The value for new cases of infection is the number of people per 100,000 among the total number for the latest week, based on reporting dates.
In Okinawa, Yamaguchi, and Hiroshima, where priority measures are being applied, the number of infected patients is continuing to increase rapidly. The number of new cases of infection in Okinawa is approximately 605, and the ratio of the number for this week to last week was 7.6, which is the highest in Japan. The infected individuals are mainly in their 20s or younger. The use rate of beds and the rate of beds for severe patients are each at slightly more than 40%. In Yamaguchi, the number of new cases of infection is approximately 81, and the ratio of this week to last week is 3.6. The use rate of beds is slightly more than 40%. In Hiroshima, the number of new cases of infection is approximately 135, and the ratio of this week to last week was 9.6. The use rate of beds is approximately 30%.
The number of new cases of infection is increasing rapidly, and has reached approximately 16 (approximately 19 in Sapporo City), with a ratio of this week to last week of 5.2. The use rate of beds is less than 10%.
The number of new cases of infection has continued to increase in Ibaraki, Tochigi, and Gunma, reaching approximately 17, 25, and 36, respectively. In each of these prefectures, the ratio of new cases for this week to last week increased rapidly, to above 2. The use rate of beds is slightly less than 20% in both Tochigi and Gunma.
In Tokyo, the number of new cases of infection has increased rapidly to approximately 57, with a ratio of this week to last week of 8.5. The infected individuals are mainly in their 20s or younger. The use rate of beds is approximately 10%. In Saitama, Chiba, and Kanagawa, the number of new cases of infection has also been increasing, reaching approximately 29, 28, and 29, respectively. In each of these prefectures, the ratio of new cases for this week to last week increased rapidly, to above 2.
In Aichi, the number of new cases of infection has increased rapidly to approximately 31, with a ratio of this week to last week of 12.0. The infected individuals are mainly in their 20s or younger. The use rate of beds is less than 10%. In Gifu, the number of new cases of infection has increased rapidly to approximately 23, with a ratio of this week to last week of 6.8. In Shizuoka and Mie, the number of new cases of infection has increased to approximately 21 and 15, respectively. In each of these prefectures, the ratio of new cases for this week to last week increased rapidly, to above 2.
In Osaka, the number of new cases of infection has increased rapidly to approximately 65, with a ratio of this week to last week of 8.2. The infected individuals are mainly in their 20s or younger. The use rate of beds is slightly less than 20%. In Shiga, Kyoto, Hyogo, and Nara, the number of new cases of infection has increased to approximately 46, 52, 27, and 44, respectively. In each of these prefectures, the ratio of new cases for this week to last week increased rapidly, to above 2. The use rate of beds is slightly less than 40% in Shiga, slightly less than 30% in Kyoto, and slightly more than 20% in Nara.
In Fukuoka, the number of new cases of infection has increased rapidly to approximately 28, with a ratio of this week to last week of 13.4. The infected individuals are mainly in their 20s or younger. The use rate of beds is less than 10%. In Saga, Kumamoto, and Kagoshima, the number of new cases of infection has increased to approximately 48, 31, and 48, respectively. In each of these prefectures, the ratio of new cases for this week to last week increased rapidly, to above 2.
The numbers of new cases of infection continued to increase rapidly in nearly all other regions, especially in Niigata, Fukui, Nagano, and Shimane. The number is approximately 25, 28, 36, and 32, respectively. The use rate of beds is slightly more than 20% in Nagano and approximately 40% in Shimane.
An immediate review of the business continuity plan of each business in the region is necessary.
Due to the rapid spread of infection in the region, infections among employees and their families, or withdrawal from the workplace due to close contact is highly likely, especially at medical institutions and nursing welfare facilities. In some regions, many healthcare professionals, such as physicians and nurses, are infected or become close contacts and are absent from work, which may result in reduced hospital functions. For this reason, it is necessary to ensure that healthcare professionals can work every day through tests, etc. even if they are close contacts with people infected with the Omicron variant. In addition, it is necessary to appropriately review the recuperation period of infected persons and the health observation period of close contacts, based on scientific knowledge. Furthermore, the same situation can occur at all workplaces that are involved in maintaining social functions, such as local governments, including healthcare centers and transportation facilities. In order to prepare for such a situation, the business continuity plan should be inspected, while taking into account the recently revised Basic Policies for Novel Coronavirus Disease Control. In addition, working from home should be encouraged in the workplace.
The provision of information to unvaccinated people and those receiving booster vaccinations must be strengthened.
Amidst concerns about the rapid spread of the Omicron variant, it is particularly necessary to promote the vaccination of unvaccinated people, and local governments must enhance the communication of information to those who have not yet been vaccinated. At the same time, booster vaccinations, which have already been started, must also be implemented steadily. In doing so, it is necessary to smoothly carry out an acceleration of the schedule for healthcare professionals and the elderly, who are at a high risk of becoming severely ill. In addition, the oral therapeutic drug that was approved by the fast-track system is expected to have a certain effect on preventing deterioration. Medical institutions that perform follow-up observation of patients at home are required to accelerate registration, as the institution that prescribes the oral therapeutic drug. In addition, in regions where the infection is spreading, it is necessary to actively perform tests for employees at facilities for the elderly, based on the Basic Policies for Novel Coronavirus Disease Control.
The cooperation of citizens and businesses is crucial to prevent the spread of the infection.
In order to protect the lives of both yourself and your family, and at the same time prevent the spread of infection by the Omicron variant, it is recommended to refrain from going out if you feel a little unwell, such as a mild fever or fatigue, and to proactively be examined and receive tests. Particularly in areas where the rapid spread of infection is causing concern regarding a strain on the medical care provision system, more careful judgment and actions are required. Crowded places and places with a high risk of infection must be avoided when going out. When it is necessary to use restaurants, it is necessary to select a third party-certified restaurant that implements infection control measures such as good ventilation, with as few people as possible, to avoid loud noises and long hours, and to wear a mask when not eating or drinking.
Figures (Number of new infections reported etc.) (PDF)
66th meeting of the COVID-19 advisory board of Ministry of Health, Labour and Welfare (January 6, 2022). Material 1
Effective reproduction number:On a national basis, the most recent number remains above 1 at 1.31 (as of December 21). The figure is 1.26 in the Tokyo metropolitan area and 1.35 in the Kansai area.
Immediate review of the business continuity plan of each facility in the region is needed.
Due to the rapid spread of infection in the region, infection of employees and their families or withdrawal from the workplace due to close contact is highly likely, especially in medical institutions and nursing welfare facilities. The same thing can happen at all workplaces involved in maintaining social functions, such as local governments including healthcare centers and transportation facilities. This is a business continuity plan review to prepare for such a situation. The use of telework is also required in the workplace.
The provision of information to unvaccinated people and those receiving booster vaccination must be reinforced.
Amid concerns about the rapid spread of the Omicron variant, it is especially necessary to promote vaccination of unvaccinated people, and local governments must enhance the communication of information to those who still have to be vaccinated. At the same time, the booster vaccination that started in December last year must also be steadily implemented. In doing so, it is necessary to smoothly carry out the acceleration of the schedule for healthcare professionals and the elderly at high risk of becoming severely ill. In addition, since specially approved oral medications can be used in patients at high risk of mild to moderate aggravation, they are expected to improve access to treatment and have a certain preventive effect on aggravation.
The cooperation of citizens and businesses is crucial to prevent the spread of infection.
In celebrating the New Year, at annual events such as New Year's parties and coming-of-age ceremonies, when eating and drinking out, it is necessary to select a third part-certified restaurant having good ventilation, with as few people as possible, avoiding loud noises and long hours, and wearing a mask when not eating or drinking. Crowded places and places with a high risk of infection must be avoided when going out. In order to protect your own life and at the same time to prevent the spread of infection by the Omicron variant, it is recommended to refrain from going out if you feel a little unwell, such as mild fever or fatigue, and to proactively be examined and receive tests. Particularly in areas where the rapid spread of infection is causing concern about strain on the medical care provision system, more careful judgment and action are required.
Figures (Number of new infections reported etc.) (PDF)
65th meeting of the COVID-19 advisory board of Ministry of Health, Labour and Welfare (December 28, 2021). Material 1
Effective reproduction number:On a national basis, the most recent number remains above 1 at 1.21 (as of December 12). The figure is 1.22 in the Tokyo metropolitan area and 1.06 in the Kansai area.
Figures (Number of new infections reported etc.) (PDF)
January 5, 2022
National Institute of Infectious Diseases Disease Control and Prevention Center, National Center for Global Health and Medicine
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to cause significant morbidity and mortality globally. Since the first detection of a new SARS-CoV-2 variant belonging to the Pango lineage B.1.1.529 (Omicron variant), it has been spreading rapidly around the world. The World Health Organization classified the SARS-CoV-2 variant belonging to B.1.1.529 as a Variant of Concern (VOC) due to possible changes in viral characteristics. The Omicron variant contains a larger number of mutations in its spike protein, resulting in substantial changes in its infectivity, transmissibility and/or immune evasion capabilities and raising a serious public health concern globally.
In Japan, individuals infected with SARS-CoV-2 are hospitalized in accordance with the Infectious Diseases Control Law or the Quarantine Act. Since the evidence is lacking on the Omicron variant, individuals infected with the Omicron variant (Omicron cases) have different discharge criteria from those infected with non-Omicron variants of SARS-CoV-2 (non-Omicron cases) after November 30, 2021 in Japan. According to the criteria for discharge of Omicron cases as of January 5, 2022, they are released from medical facilities after two consecutive negative tests by nucleic acid amplification or antigen quantification methods. However, there is a concern that these discharge criteria may lead to prolonged hospitalization and increase the burden on cases, medical facilities, as well as public health centers/institutions. Therefore, it is necessary to examine the duration of virus shedding in Omicron cases in order to provide evidence to simplify the discharge criteria.
Since December 3, 2021, the National Institute of Infectious Diseases (NIID) and the Disease Control and Prevention Center within the National Center for Global Health and Medicine (NCGM/DCC) have jointly initiated an investigation on Omicron cases in collaboration with several medical facilities in Japan. Here, we examined the duration of infectious virus shedding in Omicron cases identified early in this investigation. A total of 83 respiratory specimens from 21 cases (19 vaccinees and 2 unvaccinated cases; 4 asymptomatic and 17 mild cases) were subjected to SARS-CoV-2 RNA quantification using quantitative reverse transcriptase polymerase chain reaction and virus isolation tests. The date of specimen collection for diagnosis or symptom onset was defined as day 0. The amount of viral RNA was highest on 3-6 days after diagnosis or 3-6 days after symptom onset, and then gradually decreased over time, with a marked decrease after 10 days since diagnosis or symptom onset (Figure). The positive virus isolation results showed a similar trend as the viral RNA amount, and no infectious virus in the respiratory samples was detected after 10 days since diagnosis or symptom onset (Table). These findings suggest that vaccinated Omicron cases are unlikely to shed infectious virus 10 days after diagnosis or symptom onset.
Acknowledgement
We thank the following medical facilities for their contribution in providing us with valuable patient information and samples: National Center for Global Health and Medicine, Rinku General Medical Center.
Figure. Kinetics of viral RNA amount in respiratory samples obtained from Omicron variant infected cases
(A and B) Quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) done at NIID for all respiratory samples received using NIID-N2 primer/probe set for cases of SARS-CoV-2 Omicron variant infection. The levels of viral RNA by (A) days since diagnosis or (B) days since symptom onset. Red bars indicate median Cq value with interquartile range. Dotted line indicates a cutoff value.
(A) Number and percentage of viral RNA positive or virus isolation positive samples by days since diagnosis
Days since diagnosis |
Number and percentage of viral RNA positive samples n (%) |
Number and percentage of virus isolation positive samples n (%) |
Number and percentage of virus isolation positive in viral RNA positive samples n (%) |
0 ~ 2 days |
20/21 (95.2) |
2/21 (9.5) |
2/20 (10.0) |
3 ~ 6 days |
14/17 (82.4) |
7/17 (41.2) |
7/14 (50.0) |
7 ~ 9 days |
17/18 (94.4) |
2/18 (11.1) |
2/17 (11.8) |
10 ~ 13 days |
4/15 (26.7) |
0/15 (0) |
0/4 (0) |
After 14 days |
5/12 (41.7) |
0/12 (0) |
0/5 (0) |
(B) Number and percentage of viral RNA positive or virus isolation positive samples by days since symptom onset (symptomatic cases only)
Days since symptom onset |
Number and percentage of viral RNA positive samples n (%) |
Number and percentage of virus isolation positive samples n (%) |
Number and percentage of virus isolation positive in viral RNA positive samples n (%) |
-1 ~ 2 days |
15/16 (93.8) |
2/16 (12.5) |
2/15 (13.3) |
3 ~ 6 days |
8/8 (100) |
4/8 (50.0) |
4/8 (50.0) |
7 ~ 9 days |
16/16 (100) |
3/16 (18.8) |
3/16 (18.8) |
10 ~ 13 days |
7/12 (58.3) |
0/12 (0) |
0/7 (0) |
After 14 days |
4/10 (40.0) |
0/10 (0) |
0/4 (0) |
(C) Number and percentage of viral RNA positive or virus isolation positive samples by days since diagnosis (asymptomatic cases only)
Days since positive test |
Number and percentage of viral RNA positive samples n (%) |
Number and percentage of virus isolation positive samples n (%) |
Number and percentage of virus isolation positive in viral RNA positive samples n (%) |
0 ~ 5 days |
6/6 (100) |
3/6 (50.0) |
3/6 (50.0) |
6 ~ 9 days |
3/4 (75.0) |
0/4 (0) |
0/3 (0) |
After 10 days |
1/10 (10) |
0/10 (0) |
0/1 (0) |
64th meeting of the COVID-19 advisory board of Ministry of Health, Labour and Welfare (December 22, 2021). Material 1
Effective reproduction number:On a national basis, the most recent number is above 1 at 1.11 (as of December 5). The figure is 1.23 in the Tokyo metro area and 1.02 in the Kansai area.
Figures (Number of new infections reported etc.) (PDF)
63th meeting of the COVID-19 advisory board of Ministry of Health, Labour and Welfare (December 16, 2021). Material 1
Effective reproduction number:On a national basis, the most recent number remains below 1 at 0.96 (as of November 28), with values of 1.01 in the Tokyo metro area and 0.90 in the Kansai area.
Figures (Number of new infections reported etc.) (PDF)
62th meeting of the COVID-19 advisory board of Ministry of Health, Labour and Welfare (December 8, 2021). Material 1
Effective reproduction number:On a national basis, the most recent number remains below 1 at 0.87 (as of November 21), with values of 0.91 in the Tokyo metro area and 0.74 in the Kansai area.
Figures (Number of new infections reported etc.) (PDF)